Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors.

MLA

Afzelius, Lovisa, et al. “Conformer- and Alignment-Independent Model for Predicting Structurally Diverse Competitive CYP2C9 Inhibitors.” Journal of Medicinal Chemistry, vol. 47, no. 4, Feb. 2004, pp. 907–14. EBSCOhost, https://doi.org/10.1021/jm030972s.

APA

Afzelius, L., Zamora, I., Masimirembwa, C. M., Karlén, A., Andersson, T. B., Mecucci, S., Baroni, M., & Cruciani, G. (2004). Conformer- and alignment-independent model for predicting structurally diverse competitive CYP2C9 inhibitors. Journal of Medicinal Chemistry, 47(4), 907–914. https://doi.org/10.1021/jm030972s

Chicago

Afzelius, Lovisa, Ismael Zamora, Collen M Masimirembwa, Anders Karlén, Tommy B Andersson, Silvio Mecucci, Massimo Baroni, and Gabriele Cruciani. 2004. “Conformer- and Alignment-Independent Model for Predicting Structurally Diverse Competitive CYP2C9 Inhibitors.” Journal of Medicinal Chemistry 47 (4): 907–14. doi:10.1021/jm030972s.